Adjuvant Therapy After Surgical Stone Management

Advances in Chronic Kidney Disease

Volumn 16, Issue 1, 2009, Pages 52-59

  Ferrandino, Michael N ^a   Monga, Manoj ^a   Preminger, Glenn M ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Calculi; Kidney; Medical expulsive therapy; Nephrolithiasis; Percutaneous nephrolithotomy; Shockwave lithotripsy; Ureteroscopy

Indexed keywords

ALFUZOSIN; ALLOPURINOL; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CITRATE POTASSIUM SODIUM; DIURETIC AGENT; KETOROLAC; LIDOCAINE; MANNITOL; NONSTEROID ANTIINFLAMMATORY AGENT; OXYBUTYNIN; PHYLLANTHUS NIRURI EXTRACT; TAMM HORSFALL GLYCOPROTEIN; VERAPAMIL;

ADJUVANT THERAPY; ALKALINITY; ALTERNATIVE MEDICINE; ARTICLE; DIURESIS; EXTRACORPOREAL LITHOTRIPSY; HUMAN; KIDNEY INJURY; KIDNEY PAIN; KIDNEY TUBULE PRESSURE; MEDLINE; NEPHROLITHIASIS; NONHUMAN; PAIN ASSESSMENT; PERCUTANEOUS NEPHROLITHOTOMY; POSTOPERATIVE PAIN; PRIORITY JOURNAL; RENAL PROTECTION; THERAPY EFFECT; ULTRASONIC LITHOTRIPSY; URETER STENT; URETEROSCOPY; VISUAL ANALOG SCALE;

ADRENERGIC ALPHA-ANTAGONISTS; ALKALIES; ANTIOXIDANTS; COMBINED MODALITY THERAPY; HUMANS; LITHOTRIPSY; NEPHROLITHIASIS; NEPHROSTOMY, PERCUTANEOUS; RECURRENCE;

EID: 57449105678     PISSN: 15485595     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ackd.2008.10.007     Document Type: Article

References (49)

1. Stamatelou K.K., Francis M.E., Jones C.A., et al. Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int 63 (2003) 1817-1823
2. Streem S.B., Yost A., and Mascha E. Clinical implications of clinically insignificant store fragments after extracorporeal shock wave lithotripsy. J Urol 155 (1996) 1186-1190
3. Raman J.D., Gupta A., Bensalah K., et al. Natural history of residual fragments following percutaneous nephrostolithotomy. Presented at the AUA Annual Meeting, Chicago, April 2008 (abstract). J Urol 179 (2008) 466
4. Cicerello E., Merlo F., Gambaro G., et al. Effect of alkaline citrate therapy on clearance of residual renal stone fragments after extracorporeal shock wave lithotripsy in sterile calcium and infection nephrolithiasis patients. J Urol 151 (1994) 5-9
5. Cicerello E., Merlo F., Maccatrozzo L., et al. Urolithiasis 2000. In: Rodgers A.L., Hibbert B.E., Hess B., et al. (Eds). Effect of potassium citrate therapy on clearance of residual stone fragments after ESWL in calcium nephrolithiasis patients (2000), University of Cape Town, Cape Town, South Africa 592
6. Soygur T., Akbay A., and Kupeli S. Effect of potassium citrate therapy on stone recurrence and residual fragments after shockwave lithotripsy in lower caliceal calcium oxalate urolithiasis: a randomized controlled trial. J Endourol 16 (2002) 149-152
7. Arrabal-Martín M., Fernández-Rodríguez A., Arrabal-Polo M.A., et al. Extracorporeal renal lithotripsy: Evolution of residual lithiasis treated with thiazides. Urology 68 (2006) 956-959
8. Hollingsworth J.M., Rogers M.A., Kaufman S.R., et al. Medical therapy to facilitate urinary stone passage: A meta-analysis. Lancet 368 (2006) 1171-1179
9. Porpiglia F., Destefanis P., Fiori C., et al. Role of adjunctive medical therapy with nifedipine and deflazacort after extracorporeal shock wave lithotripsy of ureteral stones. Urology 59 (2002) 835-838
10. Sarica K., Inal Y., Erturhan S., et al. The effect of calcium channel blockers on stone regrowth and recurrence after shock wave lithotripsy. Urol Res 34 (2006) 184-189
11. Gravina G.L., Costa A.M., Ronchi P., et al. Tamsulosin treatment increases clinical success rate of single extracorporeal shock wave lithotripsy of renal stones. Urology 66 (2005) 24-28
12. Bhagat S.K., Chacko N.K., Kekre N.S., et al. Is there a role for tamsulosin in shock wave lithotripsy for renal and ureteral calculi?. J Urol 177 (2007) 2185-2188
13. Kupeli B., Irkilata L., Gurocak S., et al. Does tamsulosin enhance lower ureteral stone clearance with or without shock wave lithotripsy?. Urology 64 (2004) 1111-1115
14. Sighinolfi M.C., Micali S., Celia A., et al. Efficacy of expulsive therapy using nifedipine or tamsulosin, both associated with ketoprofene, after shock wave lithotripsy of ureteral stones. Urol Res 35 (2007) 133-137
15. Fine J.K., Pak C.Y., and Preminger G.M. Effect of medical management and residual fragments on recurrent stone formation following shock wave lithotripsy. J Urol 153 (1995) 27-32
16. Sarica K., Erturhan S., Yurtseven C., et al. Effect of potassium citrate therapy on stone recurrence and regrowth after extracorporeal shockwave lithotripsy in children. J Endourol 20 (2006) 875-879
17. Iguchi M., Ikegami M., Kiwamoto H., et al. Effect of verapamil on urinary calcium and oxalate excretion in renal stone formers. Hinyokika Kiyo 39 (1993) 425-431
18. Sarica K., Bakir K., Yagci F., et al. Limitation of shockwave-induced enhanced crystal deposition in traumatized tissue by verapamil in rabbit model. J Endourol 13 (1999) 343-347
19. Jan C.R., Chen W.C., Wu S.N., et al. Nifedipine, verapamil and diltiazem block shock-wave-induced rises in cytosolic calcium in MDCK cells. Chin J Physiol 41 (1998) 181-188
20. Strohmaier W.L., Koch J., Balk N., et al. Limitation of shock-wave-induced renal tubular dysfunction by nifedipine. Eur Urol 25 (1994) 99-104
21. Delvecchio F.C., Brizuela R.M., Khan S.R., et al. Citrate and vitamin E blunt the shock wave-induced free radical surge in an in vitro cell culture model. Urol Res 33 (2005) 448-452
22. Munver R., Delvecchio F.C., Kuo R.L., et al. In vivo assessment of free radical activity during shock wave lithotripsy using a microdialysis system: the renoprotective action of allopurinol. J Urol 167 (2002) 327-334
23. Biri H., Ozturk H.S., Buyukkocak S., et al. Antioxidant defense potential of rabbit renal tissues after ESWL: Protective effects of antioxidant vitamins. Nephron 79 (1998) 181-185
24. Serel T.A., Ozguner F., and Soyupek S. Prevention of shock wave-induced renal oxidative stress by melatonin: An experimental study. Urol Res 32 (2004) 69-71
25. Thomas S., Ginsberg P.C., Young L.H., et al. Administration of protein kinase C bets II inhibitor during extracorporeal shock wave lithotripsy reduces free radical production. J Urol 179 (2008) 498
26. Ogiste J.S., Nejat R.J., Rashid H.H., et al. The role of mannitol in alleviating renal injury during extracorporeal shock wave lithotripsy. J Urol 169 (2003) 875-877
27. Micali S., Sighinolfi M.C., Celia A., et al. Can Phyllanthus niruri affect the efficacy of extracorporeal shock wave lithotripsy for renal stones? A randomized, prospective, long-term study. J Urol 176 (2006) 1020-1022
28. Kosar A., Ozturk A., Serel T.A., et al. Effect of vibration massage therapy after extracorporeal shockwave lithotripsy in patients with lower caliceal stones. J Endourol 13 (1999) 705-707
29. Pace K.T., Tariq N., Dyer S.J., et al. Mechanical percussion, inversion and diuresis for residual lower pole fragments after shock wave lithotripsy: A prospective, single blind, randomized controlled trial. J Urol 166 (2001) 2065-2071
30. Chiong E., Hwee S.T., Kay L.M., Liang S., Kamaraj R., and Esuvaranathan K. Randomized controlled study of mechanical percussion, diuresis, and inversion therapy to assist passage of lower pole renal calculi after shock wave lithotripsy. Urology 65 (2005) 1070-1074
31. Agah M., and Falihi A. The efficacy of acupuncture in extracorporeal shock wave lithotripsy. Urol J 1 (2004) 195-199
32. Wang S.M., Punjala M., Weiss D., et al. Acupuncture as an adjunct for sedation during lithotripsy. J Altern Complement Med 13 (2007) 241-246
33. Mora B., Iannuzzi M., Lang T., et al. Auricular acupressure as a treatment for anxiety before extracorporeal shock wave lithotripsy in the elderly. J Urol 178 (2007) 160-164
34. Roehrborn C.G., Siami P., Barkin J., et al. Adjunctive tamsulosin improves stone free rate after ureeroscopic lithotripsy of large renal and ureteric calculi: A prospective randomized study. J Urol 179 (2008) 616-621
35. Schwalb D.M., Eshghi M., Davidian M., et al. Morphological and physiological changes in the urinary tract associated with ureteral dilation and ureteropyeloscopy: An experimental study. J Urol 149 (1993) 1576-1585
36. Wilson W.T., and Preminger G.M. Intrarenal pressures generated during flexible deflectable ureterorenoscopy. J Endourol 4 (1990) 2-5
37. Jung H.U., Frimodt-Møller P.C., Osther P.J., et al. Pharmacological effect on pyeloureteric dynamics with a clinical perspective: A review of the literature. Urol Res 34 (2006) 341-350
38. Selmy G.I., Hassouna M.M., Khalaf I.M., et al. Effects of verapamil, prostaglandin F2 alpha, phenylephrine, and noradrenaline on upper urinary tract dynamics. Urology 43 (1994) 31-35
39. Weiss R., Mevissen M., Hauser D.S., et al. Inhibition of human and pig ureter motility in vitro and in vivo by the K(+) channel openers PKF 217-744b and nicorandil. J Pharmacol Exp Ther 302 (2002) 651-658
40. Jakobsen J.S., Holst U., Jakobsen P., et al. Local and systemic effects of endoluminal pelvic perfusion of isoproterenol: A dose response investigation in pigs. JUrol 177 (2007) 1934-1938
41. Jung H.U., Jakobsen J.S., Mortensen J., et al. Irrigation with isoproterenol diminishes increases in pelvic pressure without side-effects during ureterorenoscopy: A randomized controlled study in a porcine model. Scand J Urol Nephrol 42 (2008) 7-11
42. Kang D.E., Maloney M.M., Haleblian G.E., et al. Effect of medical management on recurrent stone formation following percutaneous nephrolithotomy. J Urol 177 (2007) 1785-1788
43. Norris R.D., Sur R.L., Springhart W.P., et al. A prospective, randomized, double-blinded placebo-controlled comparison of extended release oxybutynin versus phenazopyridine for the management of postoperative ureteral stent discomfort. Urology 71 (2008) 792-795
44. Beddingfield R., Pedro R., Hinck B., et al. Alfuzosin to relieve ureteral stent discomfort: A randiomized placebo-controlled study (AUA abstract 1461). J Urol 176 (2008) 499
45. Park S.C., Lee J.W., Seo I.Y., et al. The effect of alfuzosin and tolterodine in treating double-J stent-related symptoms (AUA abstract 816). J Urol 179 (2008) 289
46. Beiko D.T., Watterson J.D., Knudsen B.E., et al. Double-blind randomized controlled trial assessing the safety and efficacy of intravesical agents for ureteral stent symptoms after extracorporeal shockwave lithotripsy. J Endourol 18 (2004) 723-7330
47. Lehtoranta K., Mankinen P., Taari K., et al. Residual stones after percutaneous nephrolithotomy; sensitivities of different imaging methods in renal stone detection. Ann Chir Gynaecol 84 (1995) 43-49
48. Pearle M.S., Watamull L.M., and Mullican M.A. Sensitivity of noncontrast helical computerized tomography and plain film radiography compared to flexible nephroscopy for detecting residual fragments after percutaneous nephrostolithotomy. J Urol 162 (1999) 23-26
49. Bensalah K., Tuncel A., Gupta A., et al. Determinants of quality of life for patients with kidney stones. J Urol 179 (2008) 2238-2243